Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old ...

Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a ...

Researchers at Columbia Universityfound that while both drugs effectively lower blood pressure and help prevent heart attacks, strokes, and heart failure, chlorthalidone comes with higher risks of ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

A new study from the University of Bologna has raised concerns about a common blood pressure medication called beta-blockers.

It's reported more than 8 million Americans take a blood thinner. One has been recalled for potential absorption issues.

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...